Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
08/2012
08/23/2012US20120214733 Oxytocin receptor agonists
08/23/2012US20120214730 Method of using heparin binding motif for treating asthma
08/23/2012US20120214709 Isolating biological modulators from biodiverse gene fragment libraries
08/23/2012US20120213820 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
08/23/2012US20120213819 Hemagglutinin polypeptides, and reagents and methods relating thereto
08/23/2012US20120213790 Methods of treatment using il-16 antagonist peptides
08/22/2012EP2489371A1 Carrier peptides for drug delivery
08/22/2012EP2489364A1 Monomethylvaline compounds onjugated to antibodies
08/22/2012EP2489363A2 Agonist peptides of basic fibroblast growth factor (BFGF) and the method of reduction of wrinkle on skin, darkening of hair and acceleration of wound healing
08/22/2012EP2488545A1 Mass spectrometry quantitation of p450 protein isoforms in hepatocytes
08/22/2012EP2488543A1 Compositions and methods for producing cyclic peptoid libraries
08/22/2012EP1715042B1 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRICTED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME
08/22/2012EP1644021B1 Methods and compositions for the treatment of gastrointestinal disorders
08/22/2012EP1511764B1 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin f2alpha receptor
08/22/2012CN1865281B Specific antibody GB11 T cell epitope peptide for resisting oophoroma and its uses
08/22/2012CN102643334A Polypeptide molecule for serum in gastric cancer and application
08/22/2012CN102643333A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
08/22/2012CN102643332A Application of B cell epitope peptide of human PCT (Procalcitonin) and monoclonal antibody of B cell epitope peptide
08/22/2012CN102643331A Micromolecular peptide probe suitable for molecular image diagnosis of lung cancer and preparation method thereof
08/22/2012CN102643330A Synthetic method for aspartate hexapeptide danshensu as bone targeted drug and medical application of aspartate hexapeptide danshensu
08/22/2012CN102643329A Functional epitopes of ricin, monoclonal antibodies specifically bound with functional epitopes and use thereof in preparation of medicaments for preventing or treating ricin poisoning
08/22/2012CN101870981B Expression and purification method of heme oxygenase-1, and epitopes thereof
08/22/2012CN101560246B Thymopentin derivate, preparation method and application of derivate and compound containing derivate in preparing drugs
08/21/2012US8247534 Synthesis of radiofluorinated peptide using microwave activation technology
08/21/2012US8246987 Controlled release composition and method of producing the same
08/21/2012CA2449284C Alpha-fetoprotein peptides and uses thereof
08/16/2012WO2012108419A1 Composition that augments plant disease resistance and/or branching
08/16/2012WO2012107725A1 Materials and methods relating to cardiovascular imaging
08/16/2012WO2012087943A3 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
08/16/2012WO2012083078A3 Croos-linked peptides and proteins, methods of making same, and uses thereof
08/16/2012WO2012061082A3 Chromobacterium bioactive compositions and metabolites
08/16/2012US20120208981 Method for purification of colistin and purified colistin components
08/16/2012US20120208774 Method for inhibiting "melanoma inhibitory activity" mia
08/16/2012US20120208768 Specific binding sites in collagen for integrins and use thereof
08/16/2012US20120208747 Novel peptide for augmenting and expression of bdnf and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including alzheimer's disease or parkinson's disease, comprising the same
08/16/2012US20120208746 Genetic markers associated with response to cyclophilin-binding compounds
08/16/2012US20120207820 Composition for treatment of multiple sclerosis
08/16/2012US20120207778 Nucleic acids and proteins from streptococcus groups a and b
08/16/2012US20120207776 Conserved escherichia coli immunogens
08/16/2012US20120207775 Immunogenic Epitopes as Targets for Universal Cancer Vaccines
08/16/2012US20120207758 CD22 Exon 12 Deletion Mutants
08/15/2012EP2487183A1 Ubiquitin-isopeptide probes
08/15/2012EP2486933A1 Monomethylvaline compounds conjugated with antibodies
08/15/2012EP2303911B1 A synthetic peptide consisting of bone forming peptide 2(bfp 2) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
08/15/2012EP2170930B1 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
08/15/2012EP2030628B1 A peptide for preventing or treating liver damage and its derivant and the use
08/15/2012EP1705182B1 Antitumoral and antiviral peptides
08/15/2012CN102639556A Polypeptides and uses thereof
08/15/2012CN102639555A Bladder cancer specific ligand peptides
08/15/2012CN102639140A Novel peptides, process for preparation thereof, and use thereof
08/15/2012CN102633865A Method for pretreating enramycin fermentation liquor and method for preparing enramycin premix by using enramycin fermentation liquor
08/15/2012CN102633864A GPC3 antigen polypeptide, anti-GPC3 polyclonal antibody and application thereof
08/15/2012CN102633863A New approach to treat intraocular hypertension
08/15/2012CN102321156B Novel thymopentin compound and composition powder injection thereof
08/15/2012CN101845080B Angiotensin converting enzyme inhibitory peptide and preparation method thereof
08/15/2012CN101619092B Tumor antigen TRAG-3 mimotope peptide and application thereof
08/15/2012CN101497656B Polypeptide with high combination activity with integrin alpha v beta 3 and use thereof
08/15/2012CN101039953B Therapeutic and diagnostic agents
08/14/2012USRE43581 Peptide epitopes of apolipoprotein B
08/14/2012US8242239 MHC molecule-binding tumor-associated peptides
08/14/2012US8242088 Carrier vectors through an epithelium with tight junctions
08/14/2012US8242084 Dimerized peptide
08/14/2012US8241856 Using filaggrin concentration in bodily fluids to diagnose arthritic disorders; immunoassay
08/14/2012CA2407905C Antibodies capable to selectively detect prion prpsc isoforms
08/09/2012WO2012105595A1 Drug delivery material capable of passing through blood-brain barrier, and peptide and use thereof
08/09/2012WO2012104500A1 Novel peptides involved in the scf c-kit signalling pathway and compositions comprising same
08/09/2012WO2012104462A1 Heptapeptides and the use thereof for controlling hypertension
08/09/2012WO2012103800A1 Method for preparing cyclic lipopeptide compound
08/09/2012WO2012078734A3 Polypeptide derived from calcitonin receptors and methods of use
08/09/2012WO2012054500A3 Compositions for drug administration
08/09/2012US20120203102 Azulene and azaazulene systems for imaging, monitoring and therapy
08/09/2012US20120202969 Compound, phosphorylation inhibitor, insulin resistance improving agent, preventive or therapeutic agent for diabetes, and screening method
08/09/2012US20120202968 2-Amino-3-methyl-hex-5-enoic acid and its use in the prodction of peptides such as bacitracins
08/09/2012US20120202754 Enhanced substrates for the protease activity of serotype a botulinum neurotoxin
08/09/2012US20120202737 New bacitracin antibiotics
08/09/2012US20120202733 Inhibition of trem receptor signaling with peptide variants
08/09/2012US20120202298 HTS Fluorescence Polarization Assay for Inhibitors of Keap1-Nrf2 Interaction
08/09/2012US20120202263 Bioactive Macromers and Hydrogels and Methods for Producing Same
08/09/2012US20120202247 Method, computing routine, device for predicting properties of mhc/peptide complexes, and data and peptides produced therefrom
08/09/2012US20120202219 Psa capture agents, compositions, methods and preparation thereof
08/09/2012US20120201858 Multiple-arm peptide compounds, methods of manufacture and use in therapy
08/09/2012US20120201841 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
08/09/2012US20120201840 EphA2 T-Cell Epitopes and Uses Therefor
08/09/2012US20120201782 Peptide, adjuvants, vaccines, and methods of use
08/09/2012DE10113776B4 Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins An isolated streptavidinbindendes competitively elutable peptide, this complete fusion peptide, nucleic acid coding therefor, expression vector, to methods for producing a recombinant fusion protein, and methods for the detection and / or for the recovery of the fusion protein
08/09/2012CA2826037A1 Method for preparing cyclic lipopeptide compound
08/08/2012EP2484689A1 Peptide inhibiting differentiation of hematopoietic stem cells or hematopoietic precursor cells and use of same
08/08/2012EP2483300A1 Synthetic myostatin peptide antagonists
08/08/2012EP2268657B1 Histidine related compounds for identifying and blocking amyloid beta ion channels
08/08/2012EP2229402B1 Synthetic peptides immuno-reactive with rheumatoid arthritis auto-antibodies
08/08/2012EP2046815B1 Anti-inflammatory and antiallergic cyclic peptides
08/08/2012CN102627689A Hydrate of cyclopeptide compound as well as preparation method and application thereof
08/08/2012CN102627688A High purity cyclic peptide compound and preparation method and application thereof
08/08/2012CN102627687A Eriocheir sinensis GnRH analogue, and preparation method and application thereof
08/08/2012CN102627686A Polypeptide with effect of inhibiting activity of fibroblast growth factor receptor 3 and application thereof
08/08/2012CN101781359B Novel antibacterial peptide and preparation method and application thereof
08/08/2012CN101781358B Novel antibacterial peptide and preparation method and application thereof
08/08/2012CN101137670B Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody
08/07/2012US8236774 Human telomerase catalytic subunit
08/07/2012US8236762 Peptide-cytotoxic conjugates
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 423